期刊文献+

HPV分型检测对宫颈高度病变的筛查作用 被引量:7

Role of human papillomavirus type testing in screening of high grade cervical injury
下载PDF
导出
摘要 目的观察HPV分型检测在宫颈高度病变筛查中的作用。方法对460例行液基细胞学及HPV分型检测患者资料进行回顾性分析,其中细胞学结果≥ASCUS的患者行宫颈病理学活检。结果 257例HPV检测阳性(阳性率为55.87%),其中分型检测感染频度前6位分别为16、58、52、18、68、53型。208例宫颈细胞学异常,确诊宫颈高度病变62例,其中高危型HPV+与HPV-者分别为58例和4例(P<0.01);145例ASCUS,活检确诊宫颈高度病变39例,其中高危型HPV+与HPV-者分别为37例和2例(P<0.01);45例LSIL,确诊宫颈高度病变12例,其中高危型HPV+与HPV-者分别为11例和1例(P<0.05);18例HSIL,确诊宫颈高度病变11例,其中高危型HPV+与HPV-者分别为10例和1例(P<0.01)。结论随着宫颈细胞学和组织病理学病变级别的升高,高危型HPV感染的阳性率呈上升趋势(P<0.05)。HPV分型检测对细胞学异常者宫颈高度病变筛查有重要意义。 【Objective】 To observe the role of human papilloma virus(HPV) type testing in screening of high grade cervical injury.【Methods】 The data from 460 women undergone both TCT and HPV testing were analyzed retrospectively,and the positive cases in cytology equal or over ASCUS were referred for biopsy.【Results】 A total of 257 women were detected positive in HPV(positive rate 55.87%).The six leading types of HPV infection were as follows: 16,58,52,18,68 and 53.Among 208 cases with positive cytological detection,62 cases were diagnosed as high grade cervical injury,in which 58 were high-risk HPV positive and 4 were negative(P〈0.01).Among 145 cases of ASCUS,39 cases were diagnosed as high grade cervical injury,in which 37 were high-risk HPV positive and 2 were negative(P〈0.01).Among 45 cases of LSIL,12 cases were diagnosed as high grade cervical injury,in which 11 were high-risk HPV positive and 1 was negative(P〈0.05).Among 18 cases of HSIL,11 cases were diagnosed as high grade cervical injury,in which 10 were high-risk HPV positive and 1 was negative(P〈0.01).【Conclusions】 The positive rate of high-risk HPV increases with the increased grade of cervical lesions.HPV type detection is a useful tool for screening of high grade cervical injury.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第12期1491-1495,共5页 China Journal of Modern Medicine
关键词 HPV分型检测 宫颈高度病变 宫颈癌 human papillomavirus type testing high grade cervical intraepithelial neoplasia cervical cancer
  • 相关文献

参考文献14

  • 1National Cancer Institute. The 1988 Bethesda Systerm for reporting cervical/vaginal cytological diagnoses [J]. JAMA,1989,262: 931-934.
  • 2TARKKANEN J, ANVINEN E, NIEMNINE P, et al. HPV DNA testing as an adjunct in the management of patients with low grade cytological lesions in Finland [J]. Acta Obstet Gynecol Seand, 2007, 86(3): 367-372.
  • 3肖克林,吴丽娟,郑有为,钱靖琳,梅平,王丁,周克元.第二代杂交捕获法诊断宫颈高度病变的临床评价[J].检验医学,2009,24(6):409-412. 被引量:6
  • 4王晓静,刘玉玲.HPV分型检测在宫颈癌前病变筛查中的应用价值[J].医药论坛杂志,2008,29(7):29-30. 被引量:21
  • 5AN HI, ChO NH, LEE SY, et al, Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes deteetod with the HPV DNA chip mieroarray method [J]. Cancer, 2003, 97(7): 1672-1680.
  • 6陶萍萍,卞美璐.女性生殖道人乳头状瘤病毒基因型研究进展[J].中国实用妇科与产科杂志,2005,21(8):507-509. 被引量:38
  • 7陶萍萍,卞美璐,欧华,陈庆云,李敏,刘军.导流杂交基因芯片技术在人乳头状瘤病毒检测中应用的研究[J].中华妇产科杂志,2006,41(1):43-47. 被引量:132
  • 8KOUTSKY LA, HOLMES KK, CRITCHLOW CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in reladon to papillomavirus infection [J]. N Engl J Med, 1992, 327: 1272-1278.
  • 9LIN M, YANG LY, LI LJ,et al. Genital human papillomavirus screening by gene chip in Chinese women of Guangdang province[JJ. Aust N Z J Obstet Gynaecol, 2008, 48: 189-194.
  • 10HUANG LW, LIN YH, PAN HS, et al. Human papillomavirus genotyping as a predictor of high-grade cervical dysplasia in women with mildly eytologie abnormalities: A two-year follow-up report [J]. Diagn Cytopathol, 2011 Mar 25. doi: 10.1002/de.21591. [Epub abead of print].

二级参考文献43

共引文献203

同被引文献59

  • 1杜茜,邓永丽,张全,袁艺.人乳头瘤病毒在宫颈癌前病变诊断中的意义[J].解放军医学杂志,2006,31(5):462-464. 被引量:6
  • 2Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda Sys- tem: terminology for reporting results of cervical cytology[J]. JA- MA,2002,287(16):2114-2119.
  • 3Liao QP. Advances in the research of etiology of cervical cancer [J]. Chinese Journal of Clinical Obstetrics and Gynecol ogy,2003,4 (4):243-245.
  • 4Zur Hausen H. PapiIlomavirus infections-a major cause of human cancers[J]. Biochim Biophys Acta,1996,1288(2): F55-78.
  • 5Mukhopadhyay S,Ray S,Dhar S,et al.Evaluation of the category high-grade squamous intraepithelial lesion in the bethesda system for reporting cervical cytology[J].J Cytol,2013,30:33-35.
  • 6Racey CS,Withrow DR,Gesink D.Self-collected hpv testing improves participation in cervical cancer screening:a systematic review and meta-analysis[J].Can J Public Health,2013,104:159-166.
  • 7Roneo G,Brezzi S? Carozzi F,et al. The new technologiesfor cervical cancer screening randomized controlled trial.An overview of results during the first phase of recruit-ment[J]. Gynecol Oncol,2007 ,107(Suppl 1):230-232.
  • 8Ronco G, Giorgi-Rossi P, Carozzi F, et al. New technolo-gies for cervical cancer screening (NTCC) working group[J]. Lancet Oncol,2010,11(3) :249-257.
  • 9Meijer CJ , Berkhof J, Castle PE, et al. Guidelines for hu-man papillomavirus DNA test requirements for primarycervical cancer screening in women of 30 years and older[J]. Int J Caneer,2009,124(3) :516-520.
  • 10Bosch FX,Lorincz A,Munoz N,et al.The causal relation between human papillomavirus and cervical cancer[J].J Clin Pathol,2002,55(4):244-265.

引证文献7

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部